Lexicon Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -16.9% | -20.6% | -34.1% | +123.5% | +22.7% | -23.7% | -45.4% | -50.1% | +149.0% | -46.0% | +5.1% | +2,941.2% | -97.0% | -8.3% | +14.6% | -27.6% | -97.0% | -86.4% | +766.7% | -90.2% | -39.1% | +164.3% | -5.4% | +11.4% | -28.2% | -14.3% | +1,220.8% | -48.9% | +333.3% | +61.0% | +45.8% | +6.3% | +1,417.4% | -95.2% | +2,187.3% | -50.9% | -61.3% | +284.2% | -96.7% | – | |
| – | -23.1% | -99.4% | +138.7% | +11.5% | -10.2% | -0.9% | +57.2% | -34.2% | +3.3% | -2.8% | +140.0% | -56.5% | +34.1% | -26.6% | +28.2% | -13.0% | +56.7% | +1,171.1% | -18.7% | +52.9% | +5.2% | -99.3% | -1.8% | +0.9% | -4.6% | +8.7% | -92.9% | -12.5% | +211,785.7% | -98.8% | -5.1% | -57.2% | +36,425.4% | -99.9% | +596.7% | -95.2% | +3,090.0% | -66.1% | -63.9% | – | |
| – | – | – | -36.3% | +128.8% | +23.4% | -24.1% | -47.7% | -51.2% | +161.7% | -47.5% | -3.6% | +3,417.3% | -97.3% | -6.6% | +13.5% | -28.9% | -113.2% | – | – | – | -71,769.6% | – | – | +11.4% | -292.3% | – | +1,187.5% | -49.8% | -9,216.1% | – | +55.1% | +13.4% | -63.0% | +98.4% | +2,226.1% | -50.5% | -63.5% | +305.8% | -96.9% | – | |
| – | -23.1% | +7.9% | -38.2% | +45.3% | +20.5% | +1.3% | -44.4% | -48.2% | -10.6% | -2.3% | +5.1% | +111.0% | +52.3% | +35.9% | +3.8% | -29.9% | -97.5% | +1,171.1% | -18.7% | +52.9% | +5.2% | -10.2% | -9.9% | -21.0% | +31.4% | -13.3% | +20.9% | +20.7% | -15.9% | -3.6% | +24.0% | +46.1% | +3.5% | -42.7% | +1.8% | +20.5% | -40.3% | +13.9% | +36.7% | – | |
| – | +13.9% | +6.5% | +24.2% | -9.5% | -3.5% | -7.9% | +12.8% | -7.0% | +6.3% | +0.0% | -13.9% | -2.6% | +4.8% | +0.9% | -3.9% | -15.0% | -99.6% | +0.0% | +16,702.9% | -8.0% | +8.7% | +7.0% | +25.9% | +17.7% | -15.0% | +79.1% | +56.8% | -91.5% | +1,258.1% | -7.8% | +22.2% | +1.0% | -18.5% | -64.0% | -19.5% | -18.7% | +15.2% | +5.4% | +5.6% | – | |
| – | -16.1% | +7.5% | -22.3% | +23.0% | +13.3% | -1.0% | -30.8% | -32.3% | -1.6% | -9.5% | +2.9% | +50.8% | +36.0% | +26.6% | +4.5% | -210.5% | – | +23.9% | -3.9% | +189.6% | -61.5% | +163.5% | +3.1% | -3.8% | +30.6% | +3.2% | +42.9% | +11.8% | -34.5% | +42.0% | +22.8% | +15.0% | -49.0% | -19.3% | -7.4% | +5.8% | -24.3% | +10.2% | +23.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -121.0% | – | – | – | -108.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -426.2% | – | – | – | – | |
| – | -0.7% | -2.8% | +1.6% | +0.3% | +33.6% | +136.4% | +1.4% | +1.3% | -0.5% | -2.0% | +0.9% | +0.8% | -0.2% | -1.2% | -0.1% | -19.6% | -95.9% | -1.8% | +1.2% | +1.2% | +72.5% | -62.7% | +539.1% | +22.9% | +27.7% | +65.1% | +7.6% | +98.9% | +39.0% | -8.7% | -55.3% | +106.3% | -15.4% | -52.4% | +26.3% | -7.0% | -5.8% | -21.7% | +64.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -123.2% | – | – | – | -106.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -492.7% | – | – | – | – | |
| – | -96.7% | -23,483.8% | – | -1.4% | -297.1% | – | -0.4% | -87.2% | -113.0% | – | -127.8% | – | – | +186.0% | +435.0% | -19.6% | -104.2% | – | -60.4% | -573.7% | – | – | +504.2% | -49.7% | -26.0% | -576.4% | – | +147.7% | -204.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -122.6% | – | – | – | -106.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -492.7% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -119.9% | – | – | – | -106.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -282.1% | – | – | -4,523.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.